Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07583186 · ClinicalTrials.gov registry record · NA
Maternal Intake of Eggs and Infant Neurodevelopment
A NA study, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07583186 is a NA study that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT07583186, a NA study, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The fetal brain requires DHA, choline, lutein, and zeaxanthin (L/Z) for development, dependent on maternal intake during pregnancy. However, many pregnant women do not meet daily requirements through diet or prenatal vitamins. Egg yolks are rich in choline, and women who consume eggs daily are more likely to meet the adequate intake of 450 mg/day. A recent study by Christifano et al. found that maternal egg and neuroprotective nutrient intake predicted neurodevelopment at 32 and 36 weeks of gestation. This study aims to determine if fetal neurodevelopment is enhanced among women who consume a prenatal diet emphasizing egg consumption (EGG) versus a healthy prenatal diet education control group (HPD). Women between 12-20 weeks' gestation will be randomized into EGG and HPD groups. The EGG group will receive education on the importance of prenatal choline and egg consumption and be encouraged to consume 10-14 eggs per week. The HPD group will receive education on a healthy prenatal diet. Both groups will be encouraged to take a DHA supplement, and dietary intake of choline, L/Z, and DHA will be collected. Fetal heart rate variability will be measured at 36 weeks gestation and infant EEGs will be conducted postnatally to examine brain function. Increasing prenatal egg consumption is both economical and feasible to boost prenatal choline intake, promote offspring neurodevelopment, and guide prenatal dietary recommendations.
Interventions
- DIETARY_SUPPLEMENT Egg Supplementation
- DIETARY_SUPPLEMENT Healthy Prenatal Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2028-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07583186
The ClinicalTrials.gov registry entry for NCT07583186 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Egg Supplementation is the first listed.
NCT07583186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07583186 about?
NCT07583186 is a clinical study titled "Maternal Intake of Eggs and Infant Neurodevelopment". The fetal brain requires DHA, choline, lutein, and zeaxanthin (L/Z) for development, dependent on maternal intake during pregnancy. However, many pregnant women do not meet daily requirements through diet or prenatal vitamins. Egg yolks are rich in choline, and women who consume eggs daily are more ...
What is the current status of trial NCT07583186?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-01-01. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07583186?
The interventions under investigation include: Egg Supplementation (DIETARY_SUPPLEMENT), Healthy Prenatal Diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07583186?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.